Rudin, Charles M <br/><br/>
Phase I/II study of pemetrexed with or without ABT-751 in advanced or metastatic non-small-cell lung cancer.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Mar 2011 
 - 1075-82 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1527-7755 
<br/><br/><label>Standard No.: </label>10.1200/JCO.2010.32.5944  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Biomarkers, Tumor--blood<br/>Carcinoma, Non-Small-Cell Lung--blood<br/>Czech Republic<br/>Disease-Free Survival<br/>Double-Blind Method<br/>Female<br/>Glutamates--administration & dosage<br/>Guanine--administration & dosage<br/>Humans<br/>Kaplan-Meier Estimate<br/>Lung Neoplasms--blood<br/>Male<br/>Middle Aged<br/>Pemetrexed<br/>Proportional Hazards Models<br/>Risk Assessment<br/>Risk Factors<br/>Sulfonamides--administration & dosage<br/>Time Factors<br/>Treatment Outcome<br/>United States